GLP-3 R Retatrutide 15mg
Triple Agonist — Escalation Protocol Starter
Retatrutide 15mg — starter vial for the world's most potent weight loss peptide in Phase III development. 24% weight loss with no plateau at 48 weeks.
- 24.2% weight reduction in Phase II at 48 weeks — unprecedented
- 15mg covers 7+ weeks of starter escalation at 2mg/week
- Triple GLP-1/GIP/glucagon mechanism
- No plateau at 48 weeks — continued weight loss trajectory
- Phase III trials ongoing — most advanced pipeline compound
COA verified · US domestic shipping
Retatrutide 15mg: Entry Point to the Most Potent Weight Loss Peptide in Development
24% Weight Loss
Phase II: 24.2% body weight reduction at 48 weeks — highest ever in weight loss clinical history.
Starter Vial
15mg covers first 7+ weeks at 2mg/week — perfect for assessing tolerability.
Triple Mechanism
GLP-1 + GIP + glucagon: the glucagon arm adds hepatic fat burning and raises metabolic rate.
Phase III Active
In TRIUMPH Phase III trials — expected to be the most effective anti-obesity drug ever approved.
The Science Behind GLP-3 R Retatrutide 15mg
Retatrutide 15mg covers the first 7+ weeks of the escalation protocol at 2mg/week. The triple receptor mechanism (GLP-1 + GIP + glucagon) adds hepatic fat oxidation and metabolic rate elevation beyond dual agonists — explaining the 24% Phase II weight loss data.
Complete GLP-3 R Retatrutide 15mg Benefits
- 24.2% weight reduction in Phase II at 48 weeks — unprecedented
- 15mg covers 7+ weeks of starter escalation at 2mg/week
- Triple GLP-1/GIP/glucagon mechanism
- No plateau at 48 weeks — continued weight loss trajectory
- Phase III trials ongoing — most advanced pipeline compound
GLP-3 R Retatrutide 15mg Dosing Protocol
Escalation from 15mg Vial:
• Reconstitute with 3mL bacteriostatic water (5mg/mL)
• Weeks 1-4: 0.4mL (2mg) weekly
• Weeks 5-8: 0.8mL (4mg) weekly — all 15mg used
• Continue with 30mg or 60mg vial
All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available from Apollo Peptide Sciences for all products.
Get GLP-3 R Retatrutide 15mg
Apollo Peptide Sciences — COA verified, US domestic, fast shipping.
Shop View Stack ProtocolsGLP receptor agonists work via hypothalamic appetite regulation and metabolic enhancement — proven in large-scale clinical trials.
All Weight Loss PeptidesStacks Best With
Stack GLP-3 R Retatrutide 15mg With
Anti-AgingNAD+ 500mg
Cellular Energy & Longevity Cofactor
NAD+ is the master cellular energy molecule that declines 50% by age 50 — supplementation restores sirtuin activity, DNA repair, and mitochondrial function.
Weight LossGLP-1 S (Semaglutide)
Next-Gen GLP-1 Receptor Agonist for Weight Loss
Semaglutide (GLP-1 S) is a GLP-1 receptor agonist with clinical trials showing 15-20% body weight reduction — the most effective pharmacological weight loss agent studied.
Weight LossGLP-2 T (Tirzepatide)
Dual GIP/GLP-1 Agonist — Superior Weight Loss
Tirzepatide (GLP-2 T) is a dual GIP/GLP-1 receptor agonist showing up to 22.5% body weight reduction in trials — outperforming semaglutide in head-to-head data.